减少泊纳替尼剂量可降低CML不良事件风险

{"title":"减少泊纳替尼剂量可降低CML不良事件风险","authors":"M. Fuerst","doi":"10.1097/01.cot.0001011464.08634.3d","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"32 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ponatinib Dose Reduction Reduces Risk of Adverse Events in CML\",\"authors\":\"M. Fuerst\",\"doi\":\"10.1097/01.cot.0001011464.08634.3d\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":510505,\"journal\":{\"name\":\"Oncology Times\",\"volume\":\"32 6\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology Times\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/01.cot.0001011464.08634.3d\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Times","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.cot.0001011464.08634.3d","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}